awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40145206-7982BAAB-2518-42D8-9815-53DEFA54BA6C
Q40145206-7982BAAB-2518-42D8-9815-53DEFA54BA6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40145206-7982BAAB-2518-42D8-9815-53DEFA54BA6C
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study).
P2860
Q40145206-7982BAAB-2518-42D8-9815-53DEFA54BA6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40145206-7982BAAB-2518-42D8-9815-53DEFA54BA6C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e7b7d1aedfd0dbce05c7fb21298b11dc964c55a6
P2860
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res